KLEMP WALTER V (CEO and President) purchased 38.3% of their position (188.40K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchase worth $130.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2023ACC: 0001437749-23-035340
DirectorOfficer· CEO and President
Since Jul 2019
+188.40K
Net shares
Net buyer
$130.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
188.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+188.40K
Price / share
$0.69
Trade value
$130K
% of position
38.3%
12/26/2023
492.48K→680.88K
Total
Net shares
+188.40K
Net value
$130K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/26/2023 | P · Purchase | +188.40K | $0.69 | $130K | 38.3% | 492.48K | 680.88K |
| Total | +188.40K | $130K | ||||||
Derivative Transactions0
No derivative transactions reported